113 related articles for article (PubMed ID: 16921117)
1. Exacerbation of chronic obstructive pulmonary disease: pan-airway and systemic inflammatory indices.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Proc Am Thorac Soc; 2006 Aug; 3(6):481-2. PubMed ID: 16921117
[No Abstract] [Full Text] [Related]
2. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
4. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
[TBL] [Abstract][Full Text] [Related]
5. Clinical, functional and biochemical changes during recovery from COPD exacerbations.
Koutsokera A; Kiropoulos TS; Nikoulis DJ; Daniil ZD; Tsolaki V; Tanou K; Papaioannou AI; Germenis A; Gourgoulianis KI; Kostikas K
Respir Med; 2009 Jun; 103(6):919-26. PubMed ID: 19121927
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
7. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
8. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.
Chan KH; Yeung SC; Yao TJ; Ip MS; Cheung AH; Chan-Yeung MM; Mak JC;
Int J Tuberc Lung Dis; 2010 Sep; 14(9):1193-200. PubMed ID: 20819268
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease.
Kersul AL; Iglesias A; Ríos Á; Noguera A; Forteza A; Serra E; Agustí A; Cosío BG
Arch Bronconeumol; 2011 Apr; 47(4):176-83. PubMed ID: 21454005
[TBL] [Abstract][Full Text] [Related]
11. Eppur si muove, or COPD treatment success and inflammation.
Soriano JB; Barnes NC
Eur Respir J; 2007 Sep; 30(3):409-10. PubMed ID: 17766630
[No Abstract] [Full Text] [Related]
12. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?
Sin DD; Man SF
Thorax; 2006 Jan; 61(1):1-3. PubMed ID: 16396949
[TBL] [Abstract][Full Text] [Related]
13. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
14. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
He P
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
[No Abstract] [Full Text] [Related]
15. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
16. Clinical and inflammatory factors associated with body mass index in elderly patients with chronic obstructive pulmonary disease.
Higashimoto Y; Yamagata T; Honda N; Satoh R; Sano H; Iwanaga T; Miyhara T; Muraki M; Tomita K; Tohda Y; Fukuda K
Geriatr Gerontol Int; 2011 Jan; 11(1):32-8. PubMed ID: 20609004
[TBL] [Abstract][Full Text] [Related]
17. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.
Breyer MK; Rutten EP; Vernooy JH; Spruit MA; Dentener MA; van der Kallen C; vanGreevenbroek MM; Wouters EF
Respir Med; 2011 Jul; 105(7):1046-53. PubMed ID: 21367591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
